Resources: Page 23

Mayo Clinic Advanced Body MRI
This five-day course is intended to give radiologists the opportunity to expand their knowledge about Body MRI by highlighting state-of-the-art MR techniques for musculoskeletal, abdominal, cardiovascular, and breast imaging.
October 28, 2024November 1, 2024
Aidoc
142 W 57TH ST
New York, NY 10019
34th Annual Meeting of the Society of Radiologists in Ultrasound
This activity is structured to address a wide range of topics common to most ultrasound practices.
September 27, 2024September 29, 2024
Diagnostic Imaging: A to Z: Fundamentals to New Innovations
This event is a comprehensive review of imaging fundamentals along with recent advancements in imaging applications.
June 17, 2024
15th Annual Fetal Echocardiography: Normal and Abnormal Hearts
This course will greatly benefit physicians and sonographers in the fields of obstetric imaging, fetal echocardiography, and pediatric cardiology.
October 28, 2024October 30, 2024
58th Annual Meeting of American Society of Head and Neck Radiology
September 4, 2024September 8, 2024
The 20th Clinical Nuclear Medicine 2024
April 17, 2024April 18, 2024
The 17th Radiology After Five 2024: How to Make Night and Weekend Call a Success!
This symposium is structured to provide important and clinically advanced, information for physicians and other medical personnel who provide or use radiology services in emergency and critical care locations.
April 4, 2024April 6, 2024
SNMMI: PET/CT illuminates connection between CVD and cognitive impairment
By Kate Madden Yee
PET/CT reveals a connection between cardiovascular disease (CVD) and cognitive impairment, according to research presented at SNMMI 2024.
June 12, 2024
Brain Puzzle Dementia
SNMMI: PET-based protocol shows promise in radioligand therapy
By Amerigo Allegretto
A PET-based scout dosimetry protocol can be feasible in treating lesions with yttrium-90 FAPI (Y-90 FAPI) radioligand therapy.
June 12, 2024
Lesion uptake from a patient with a solitary fibrous tumor and its FAP expression on gallium-68 (GA-68)-FAPI-46 (A) and intratherpeutic Y-90-FAPI-46 (B). The panel shows the constructed time activity curve with the three PET/CT measurements.
SNMMI: Lu-177 PSMA-617 shines for taxane-naive prostate cancer
By Erik L. Ridley
The radiopharmaceutical Pluvicto improves survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy.
June 11, 2024
Oliver Sartor, MD
SNMMI: UW advances radioimmunotherapy At-211 production, trials
By Liz Carey
Alpha-emitting astatine-211 (At-211) may open the door to new targeted radioimmunotherapy for treating blood cancer.
June 11, 2024
Preclinical multiple myeloma studies at the University of Washington, presented during SNMMI 2024, show survival of mice at different intervals and doses of the alpha radioimmunotherapy At-211-CD38. Graphic and caption courtesy of Yawen Li, PhD.
Previous Page
Page 23 of 725
Next Page